111 related articles for article (PubMed ID: 16519125)
1. [Pseudomembranous colitis after Helicobacter pylori eradication therapy].
Kubo N; Kochi S; Ariyama I; Murata M; Furusyo N; Hayashi J
Kansenshogaku Zasshi; 2006 Jan; 80(1):51-5. PubMed ID: 16519125
[TBL] [Abstract][Full Text] [Related]
2. Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.
Trifan A; Girleanu I; Cojocariu C; Sfarti C; Singeap AM; Dorobat C; Grigore L; Stanciu C
World J Gastroenterol; 2013 Nov; 19(42):7476-9. PubMed ID: 24259981
[TBL] [Abstract][Full Text] [Related]
3. The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.
Sheu BS; Huang JJ; Yang HB; Huang AH; Wu JJ
Aliment Pharmacol Ther; 2003 May; 17(10):1283-90. PubMed ID: 12755841
[TBL] [Abstract][Full Text] [Related]
4. Pseudomembranous colitis after eradication of Helicobacter pylori infection with a triple therapy.
Harsch IA; Hahn EG; Konturek PC
Med Sci Monit; 2001; 7(4):751-4. PubMed ID: 11433206
[TBL] [Abstract][Full Text] [Related]
5. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
6. [Adverse effects of Helicobacter pylori eradication and its prevention].
Zhang S; Yanaka A
Nihon Rinsho; 2005 Nov; 63 Suppl 11():414-7. PubMed ID: 16363570
[No Abstract] [Full Text] [Related]
7. Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
Niv Y
Dig Dis Sci; 2005 May; 50(5):839-41. PubMed ID: 15906754
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial.
Ramas M; Donday MG; McNicholl AG; Gisbert JP
Gastroenterol Hepatol; 2017 Dec; 40(10):658-662. PubMed ID: 28780968
[TBL] [Abstract][Full Text] [Related]
9. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
10. Pseudomembranous colitis requiring surgical intervention following triple therapy for Helicobacter pylori eradication.
Rai R; Rai S
ANZ J Surg; 2002 Dec; 72(12):917-9. PubMed ID: 12485235
[No Abstract] [Full Text] [Related]
11. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
Shashidhar H; Peters J; Lin CH; Rabah R; Thomas R; Tolia V
J Pediatr Gastroenterol Nutr; 2000 Mar; 30(3):276-82. PubMed ID: 10749411
[TBL] [Abstract][Full Text] [Related]
12. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
Schütze K; Hentschel E
Z Gastroenterol; 1995 Nov; 33(11):651-3. PubMed ID: 8600661
[TBL] [Abstract][Full Text] [Related]
13. Pseudomembranous colitis without diarrhoea following Helicobacter pylori eradication therapy.
Lau CF; Hui PK; Fung TT; Tung SY; Wong AM; Loo CK; Lam KM
Hosp Med; 2001 Jul; 62(7):431-3. PubMed ID: 11480134
[No Abstract] [Full Text] [Related]
14. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
[TBL] [Abstract][Full Text] [Related]
15. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
Lamouliatte H; Cayla R; Zerbib F; Forestier S; de Mascarel A; Joubert-Collin M; Mégraud F
Am J Gastroenterol; 1998 Sep; 93(9):1531-4. PubMed ID: 9732938
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy.
Togawa J; Inamori M; Fujisawa N; Takahashi H; Yoneda M; Kawamura H; Abe Y; Kirikoshi H; Kobayashi N; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
Hepatogastroenterology; 2005; 52(62):645-8. PubMed ID: 15816496
[TBL] [Abstract][Full Text] [Related]
17. Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication.
Asaumi N; Niiya K; Yoshida C; Shibakura M; Niiya M; Tanimoto M
Blood Coagul Fibrinolysis; 2004 Jul; 15(5):439-40. PubMed ID: 15205594
[No Abstract] [Full Text] [Related]
18. A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy.
Yang JC; Yang KC; Hsu CT; Wang CS; Kuo CF; Wang TH
J Microbiol Immunol Infect; 1999 Mar; 32(1):1-8. PubMed ID: 11561564
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
Miwa H; Yamada T; Sato K; Ohta K; Ohkura R; Murai T; Nagahara A; Takei Y; Ogihara T; Sato N
Dig Dis Sci; 2000 Jan; 45(1):77-82. PubMed ID: 10695617
[TBL] [Abstract][Full Text] [Related]
20. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori.
Fennerty MB; Kovacs TO; Krause R; Haber M; Weissfeld A; Siepman N; Rose P
Arch Intern Med; 1998 Aug 10-24; 158(15):1651-6. PubMed ID: 9701099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
